UMedic has prospective earnings growth over the next two years


UMediC Group Bhd's manufacturing plant in Batu Kawan, Penang.

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen.

In a report, the research house said the fast growing distributor of medical equipment and manufacturer of medical consumables is backed by solid prospective earnings growth over the next two years.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
UMedic

Next In Business News

Reading the market signals
Urban harmony: Can stakeholders row together?
Breathing new life into forgotten spaces
FROM BANGSAR TO BEYOND
Asia to lead next AI wave
Luxury real estate trends in 2026
China’s gold rush continues
SC Estate Builder’s hotel acquisition under scrutiny
Department stores bet on experiences
Jakarta set to rise

Others Also Read